ASIT Biotech S.A. received the Good Manufacturing Practices (GMP) certification for its manufacturing site in Liège, Belgium, from the Federal Agency for Medicines and Health Products (FAMHP). The certification follows a 2-day site inspection from the FAMHP and the constructive dialogue with the Agency. It allows ASIT biotech to manufacture in-house the active pharmaceutical ingredient of its leading product for grass pollen allergies under GMP-compliant conditions for future clinical and commercial use.